The blood stem cell mutation, known as DNMT3A R882, leads to the growth of a large population of circulating blood cells that also contain this mutation.
Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.
This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.
Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
A new study from Weill Cornell Medicine researchers helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity.
Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.
The Presidential Advisors on Diversity and Equity have awarded three Belonging at Cornell innovation grants for 2022 programming, for projects addressing a range of topics involving diversity, equity and inclusion on all of Cornell’s campuses.